Caribou Biosciences (CRBU) executive compensation, 2026 proxy

Rachel Haurwitz, Ph.D., President and chief executive officer, was paid $1.8M in 2025, down 56% from $4.2M the year before.

Filed
April 24, 2026
Annual meeting
June 17, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.8M-56% vs prior year
CEO pay in equity
46%$847,359 in awards
CEO Target Bonus
55%Expressed as percentage of base salary
2025 Bonus Payout
85%Based on strategic goals achievement

How Ph.D. was paid

$1.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary36%Bonus17%Stock awards10%Option awards36%All other compensation1%

Named executive officers

ExecutiveTotal
Rachel Haurwitz, Ph.D.President and chief executive officer$1,840,965
Sriram Ryali, M.B.A.Chief financial officer$1,029,413
Barbara McClung, J.D.Chief legal officer$919,574

What changed and why

  • $4.2MCEO total compensation decreased from $4,213,245 in 2024 to $1,840,965 in 2025.
  • 85%Actual bonuses for fiscal year 2025 reflected 85 percent of target amounts.
  • Executive officers were granted performance based stock options in July 2025.
  • Sriram Ryali joined the company as chief financial officer on January 2, 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.